NCT00616070View on ClinicalTrials.gov

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Inflammation
Interventions
DRUG

Difluprednate

Difluprednate

OTHER

Placebo

Vehicle

Trial Locations (1)

28210

Charlotte Eye, Ear, Nose & Throat, Charlotte

All Listed Sponsors
lead

Sirion Therapeutics, Inc.

INDUSTRY

NCT00616070 - Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003) | Biotech Hunter | Biotech Hunter